Cargando…

RASAL2 Plays Inconsistent Roles in Different Cancers

RAS protein activator like 2 (RASAL2) belongs to the RAS GTPase-activating protein family and plays an important role in several cancers, including ovarian cancer, nasopharyngeal carcinoma, malignant astrocytoma, renal cell carcinoma, bladder cancer, colorectal cancer, liver cancer, triple-negative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bolun, Zhu, Wei, Jiang, Xingjun, Ren, Caiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863963/ https://www.ncbi.nlm.nih.gov/pubmed/31799194 http://dx.doi.org/10.3389/fonc.2019.01235

Ejemplares similares

Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis
por: Zhou, Quanwei, et al.
Publicado: (2020)

FOXF2 acts as a crucial molecule in tumours and embryonic development
por: He, Weihan, et al.
Publicado: (2020)

Phosphorylated Rasal2 facilitates breast cancer progression
por: Wang, Xuan, et al.
Publicado: (2019)

FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
por: Shen, Wenyue, et al.
Publicado: (2022)

Rasal2 deficiency reduces adipogenesis and occurrence of obesity-related disorders
por: Zhu, Xiaoqiang, et al.
Publicado: (2017)

RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
por: Huang, Yuting, et al.
Publicado: (2014)

The expression and function of RASAL2 in renal cell carcinoma angiogenesis
por: Hui, Ke, et al.
Publicado: (2018)

Rasal2, highlighting the importance of phosphorylation on function in tumour development
por: Galindo-Hernandez, Octavio
Publicado: (2020)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Hypermethylation of RASAL1: A Key for Renal Fibrosis
por: Mao, Yuanjie
Publicado: (2014)

RASAL1 and ROS1 Gene Variants in Hereditary Breast Cancer
por: Isidori, Federica, et al.
Publicado: (2020)

RASAL2 suppresses the proliferative and invasive ability of PC3 prostate cancer cells
por: Tailor, Krishma, et al.
Publicado: (2021)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation
por: Zhang, Wenjuan, et al.
Publicado: (2019)

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
por: Koh, Siang-Boon, et al.
Publicado: (2021)

CAPRI and RASAL impose different modes of information processing on Ras due to contrasting temporal filtering of Ca(2+)
por: Liu, Qing, et al.
Publicado: (2005)

FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review
por: Ren, Xiangqing, et al.
Publicado: (2023)

RASAL3 predicts overall survival and CD8+ T lymphocyte infiltration in lung adenocarcinoma
por: Liang, Mei, et al.
Publicado: (2022)

RASAL1 inhibits HepG2 cell growth via HIF-2α mediated gluconeogenesis
por: Meng, Fanhua, et al.
Publicado: (2017)

The Ras GTPase-Activating Protein Rasal3 Supports Survival of Naive T Cells
por: Muro, Ryunosuke, et al.
Publicado: (2015)

RASAL3 Is a Putative RasGAP Modulating Inflammatory Response by Neutrophils
por: Saito, Suguru, et al.
Publicado: (2021)

miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer
por: YAN, MEISI, et al.
Publicado: (2016)

Crucial roles of different RNA-binding hnRNP proteins in Stem Cells
por: Xie, Wen, et al.
Publicado: (2021)

How Best to Play the Role of Tumor Deposits in Stage III Colon Cancer?
por: Liu, Yunxiao, et al.
Publicado: (2022)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2022)

Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation
por: Dong, Wei, et al.
Publicado: (2022)

RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis
por: Takata, Akemi, et al.
Publicado: (2017)

Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers
por: Zhu, Wei, et al.
Publicado: (2019)

Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice
por: Li, Sinai, et al.
Publicado: (2020)

What do double-check routines actually detect? An observational assessment and qualitative analysis of identified inconsistencies
por: Pfeiffer, Yvonne, et al.
Publicado: (2020)

The consistencies and inconsistencies between distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
por: Lv, Tian-Run, et al.
Publicado: (2022)

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2023)

Hepatocyte Nuclear Factor 3β Plays a Suppressive Role in Colorectal Cancer Progression
por: Wang, Juan, et al.
Publicado: (2019)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcinoma
por: Yue, Yangyang, et al.
Publicado: (2022)

NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell Characteristics
por: Jeon, Seon-Ae, et al.
Publicado: (2020)

Enteric Glia Play a Critical Role in Promoting the Development of Colorectal Cancer
por: Yuan, Robert, et al.
Publicado: (2020)

Preoperative staging of uterine cancer: can transvaginal ultrasonography play a role?
por: Rei, Mariana, et al.
Publicado: (2023)

Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
por: Jiang, Bolun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bv041hfhnqoe893jekpbd8bp44